Quest Diagnostics generated $11.3B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $1.0B with a 9.08% net margin. Gross margin stands at 33.2% and operating margin at 14.27%. Diluted EPS is $9.05, which grew 0.1% year-over-year. Based on the Q1 2026 filing.